Vertex Pharmaceuticals Incorporated logo

Vertex Pharmaceuticals Incorporated

NASDAQ:VRTX

Overview | Financials
Company Name Vertex Pharmaceuticals Incorporated
Symbol VRTX
Currency USD
Price 504.77
Market Cap 129,619,888,300
Dividend Yield 0%
52-week-range 377.85 - 519.88
Industry Biotechnology
Sector Healthcare
CEO Dr. Reshma Kewalramani FASN, M.D.
Website https://www.vrtx.com

An error occurred while fetching data.

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF

Related Stocks

Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc.

REGN

666.87 USD

Intuitive Surgical, Inc. logo

Intuitive Surgical, Inc.

ISRG

484.44 USD

Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILD

111.44 USD

Moderna, Inc. logo

Moderna, Inc.

MRNA

34.62 USD

Illumina, Inc. logo

Illumina, Inc.

ILMN

85.6 USD

Walgreens Boots Alliance, Inc. logo

Walgreens Boots Alliance, Inc.

WBA

11.23 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

415.3 USD

Biogen Inc. logo

Biogen Inc.

BIIB

139.44 USD

Financials

Numbers are in millions USD

Numbers are in millions USD